These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 27367910)
1. Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease. Logue OC; McGowan JW; George EM; Bidwell GL Curr Opin Nephrol Hypertens; 2016 Sep; 25(5):404-9. PubMed ID: 27367910 [TBL] [Abstract][Full Text] [Related]
2. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice. Ku CH; White KE; Dei Cas A; Hayward A; Webster Z; Bilous R; Marshall S; Viberti G; Gnudi L Diabetes; 2008 Oct; 57(10):2824-33. PubMed ID: 18647955 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) in the pathogenesis of diabetic nephropathy of type 1 diabetes mellitus. Mironidou-Tzouveleki M; Tsartsalis S; Tomos C Curr Drug Targets; 2011 Jan; 12(1):107-14. PubMed ID: 20735351 [TBL] [Abstract][Full Text] [Related]
4. Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression. Kanellis J; Paizis K; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA Kidney Int; 2002 May; 61(5):1696-706. PubMed ID: 11967019 [TBL] [Abstract][Full Text] [Related]
5. Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. Mattot V; Moons L; Lupu F; Chernavvsky D; Gómez RA; Collen D; Carmeliet P J Am Soc Nephrol; 2002 Jun; 13(6):1548-60. PubMed ID: 12039984 [TBL] [Abstract][Full Text] [Related]
6. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Kang DH; Anderson S; Kim YG; Mazzalli M; Suga S; Jefferson JA; Gordon KL; Oyama TT; Hughes J; Hugo C; Kerjaschki D; Schreiner GF; Johnson RJ Am J Kidney Dis; 2001 Mar; 37(3):601-11. PubMed ID: 11228186 [TBL] [Abstract][Full Text] [Related]
7. Vascular growth factors play critical roles in kidney glomeruli. Gnudi L; Benedetti S; Woolf AS; Long DA Clin Sci (Lond); 2015 Dec; 129(12):1225-36. PubMed ID: 26561594 [TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury. Oe Y; Fushima T; Sato E; Sekimoto A; Kisu K; Sato H; Sugawara J; Ito S; Takahashi N Sci Rep; 2019 Feb; 9(1):2986. PubMed ID: 30814628 [TBL] [Abstract][Full Text] [Related]
10. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis. Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687 [TBL] [Abstract][Full Text] [Related]
11. Glomerular endothelial cell injury and cross talk in diabetic kidney disease. Fu J; Lee K; Chuang PY; Liu Z; He JC Am J Physiol Renal Physiol; 2015 Feb; 308(4):F287-97. PubMed ID: 25411387 [TBL] [Abstract][Full Text] [Related]
12. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872 [TBL] [Abstract][Full Text] [Related]
13. Slit2/Robo1 signaling is involved in angiogenesis of glomerular endothelial cells exposed to a diabetic-like environment. Liu J; Hou W; Guan T; Tang L; Zhu X; Li Y; Hou S; Zhang J; Chen H; Huang Y Angiogenesis; 2018 May; 21(2):237-249. PubMed ID: 29299781 [TBL] [Abstract][Full Text] [Related]